Immunohistochemical staining of dystrophin on formalin-fixed paraffin-embedded sections in Duchenne/Becker muscular dystrophy and manifesting carriers of Duchenne muscular dystrophy

Neuromuscular Disorders

Volumn 10, Issue 6, 2000, Pages 425-429

  Hoshino, Sachiko ^a   Ohkoshi, Norio ^a   Watanabe, Masahiko ^a   Shoji, Shin'ichi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Catalyzed signal amplification system; Dystrophin; Immunohistochemical staining; Muscle tissue

Indexed keywords

ANTIBODY; DYSTROPHIN; MONOCLONAL ANTIBODY; PEROXIDASE;

ADOLESCENT; ADULT; ANTIBODY LABELING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING; SIGNAL DETECTION;

3,3'-DIAMINOBENZIDINE; ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; BIOTIN; CHILD; CHILD, PRESCHOOL; COLORING AGENTS; DYSTROPHIN; FEMALE; HETEROZYGOTE; HUMANS; HYDROGEN PEROXIDE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PEROXIDASE; SARCOLEMMA; SENSITIVITY AND SPECIFICITY; STREPTAVIDIN; TYRAMINE;

EID: 0034255708     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(99)00116-9     Document Type: Article

References (19)

1. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:1987;919-928.
2. Koenig M., Beggs A.H., Moyer M., et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 45:1989;498-506.
3. denDunnen J.T., Grootscholten P.M., Bakker E., et al. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet. 45:1989;835-847.
4. Hu X., Ray P.N., Murphy E.G., Thompson M.W., Worton R. Duplicational mutation at the Duchenne muscular dystrophy locus: Its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet. 46:1990;682-695.
5. Prior T.W., Papp A.C., Syder P.J., et al. Heteroduplex analysis of the Dystrophin gene: application to point mutation and carrier detection. Am J Med Genet. 50:1994;68-73.
6. Gardner R.J., Bobrow M., Roberts R.G. The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test. Am J Hum Genet. 57:1995;311-320.
7. Sitnik R., Campiotto S., Vainzof M., et al. Novel point mutations in the dystrophin gene. Hum Mutat. 10:1997;217-222.
8. Bonilla E., Samitt C.E., Miranda A.F., et al. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell. 54:1988;447-452.
9. Arahata K., Ishihara T., Kamakura K., et al. Mosaic expression of dystrophin in symptomatic carriers of Duchenne's muscular dystrophy. N Engl J Med. 320:1989;138-142.
10. Bobrow M.N., Litt G.J., Shaughnessy K.J., Mayer P.C., Conlon J. The use of catalyzed reporter deposition as a means of signal amplification in a variety of formats. J Immunol Methods. 150:1992;145-149.
11. Adams J.C. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem. 40:1992;1457-1463.
12. Chamberlain J.S., Gibbs R.A., Ranier J.E., Nguyen P.N., Caskey C.T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 16:1988;11141-11156.
13. Beggs A.H., Koenig M., Boyce F.M., Kunkel L.M. Detection of 98% of DMD/ BMD gene deletions by polymerase chain reaction. Hum Genet. 86:1990;45-48.
14. Heras A., Phillips T., Key M. Handbook - Immunostaining of lymphocyte markers in formalin-fixed paraffin embedded tissues using catalyzed signal amplification. 1997;Dako, Carpinteria.
15. Reed J.A., Nador R.G., Spaulding D., Tani Y., Cesarman E., Knowles D.M. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system. Blood. 91:1998;3825-3832.
16. Gresik E.W., Kashimata M., Kadoya Y., Mathews R., Minami N., Yamashina S. Expression of epidermal growth factor receptor in fetal mouse submandibular gland detected by a biotinyltyramide-based catalyzed signal amplification method. J Histochem Cytochem. 45:1997;1651-1657.
17. Sanno N., Teramoto A., Sugiyama M., Itoh Y., Osamura Y. Application of catalyzed signal amplification in immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas. Clin Pathol. 106:1996;16-21.
18. Monaco A.P., Bertelson C.J., Coletti-Feener C., Kunkel L.M. Localization and cloning of Xp2l deletion breakpoints involved in muscular dystrophy. Hum Genet. 75:1987;221-227.
19. Hu X., Burghes A.H.M., Ray P.N., Thompson M.W., Murphy E.G., Worton R.G. Partial gene duplication in Duchenne and Becker muscular dystrophy. J Med Genet. 25:1988;369-376.